Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 4Urinary Bladder Neoplasms 2Uterine Cervical Neoplasms 1Smoking Cessation 1Prostatic Hyperplasia 1Papillomavirus Infections 1Non-melanomatous Skin Cancer 1Lung Neoplasms 1Colonic Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms 1

Interventions

polyphenon E 1mirabegron 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1TroVax 1Radiotherapy 1Needles 1Electroacupuncture 1Doxazosin 1Docetaxel 1Celecoxib 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Prostatic Hyperplasia × polyphenon E × Clear all
NCT00596011 2019-10-04

Study of Polyphenon E in Men With High-grade Prostatic Intraepithelial Neoplasia

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Completed
97 enrolled 13 charts
Genitourinary

Prostatic Hyperplasia, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡